...
首页> 外文期刊>Heart rhythm: the official journal of the Heart Rhythm Society >Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study
【24h】

Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study

机译:用双抗血小板治疗治疗的非抗性心房颤动患者的血栓栓塞,出血和死亡率风险与口服抗凝血剂(基于人群)的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND Dual antiplatelet therapy (DAPT) with aspirin plus clopidogrel is used for stroke prevention in patients with atrial fibrillation (AF) who refuse to take use oral anticoagulants (OACs). However, clinical data comparing these treatments are limited.
机译:背景技术与阿司匹林加氯吡格雷的双抗血小板治疗(DAPT)用于心房颤动患者(AF)拒绝服用口服抗凝血剂(OAC)的患者中卒中预防。 然而,比较这些治疗的临床数据有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号